Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/18/24 20:24 | 1/18/24 | RGLS | Health | Drug | Pharmaceutical Preparations | Calsada Crispina | CA | O | CFO | S | -7 | 1.19 | 0 | -5 | -49 | 6 | D | ||||||||||||||
1/18/24 20:23 | 1/18/24 | RGLS | Health | Drug | Pharmaceutical Preparations | Aker Christopher Ray | CA | O | SVP,GC | S | -7 | 1.19 | 0 | -5 | -35 | 10 | D | ||||||||||||||
1/18/24 20:22 | 1/18/24 | RGLS | Health | Drug | Pharmaceutical Preparations | Hagan Joseph P | CA | DO | CEO | S | -17 | 1.19 | 0 | -15 | -20 | 57 | D | ||||||||||||||
2/7/22 17:09 | 2/4/22 | RGLS | Health | Drug | Pharmaceutical Preparations | Drygin Denis | CA | O | Chief Sc | P | 5 | 0.2300 | 0 | 23 | New | 23 | D | ||||||||||||||
1/26/22 16:13 | 1/26/22 | RGLS | Health | Drug | Pharmaceutical Preparations | Hagan Joseph P | CA | DO | P,CEO | P.d | 22 | 0.2152 | 0 | 100 | 32 | 417 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |